TTRNA-DC vaccine/TTRNA-xALT immunotherapy (University of Florida)

N/A

Report date: 2024/02/23 15:47:24

Base Information

Drug NameTTRNA-DC vaccine/TTRNA-xALT immunotherapy (University of Florida)

Drug Alias NameAutologous dendritic cell vaccine/T-cell therapyTumor RNA-loaded dendritic cell vaccine/Tumor-specific T-cell therapy (University of Florida)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes TTRNA-xALT

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Florida

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Florida

Inactive CompaniesN/A

Active IndicationsGlioma

Inactive IndicationsN/A

Other Information

ATC CodeN/A